377 related articles for article (PubMed ID: 18511846)
61. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.
Wang F; Okamoto Y; Inoki I; Yoshioka K; Du W; Qi X; Takuwa N; Gonda K; Yamamoto Y; Ohkawa R; Nishiuchi T; Sugimoto N; Yatomi Y; Mitsumori K; Asano M; Kinoshita M; Takuwa Y
J Clin Invest; 2010 Nov; 120(11):3979-95. PubMed ID: 20978351
[TBL] [Abstract][Full Text] [Related]
62. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
63. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.
Wautier MP; Chappey O; Corda S; Stern DM; Schmidt AM; Wautier JL
Am J Physiol Endocrinol Metab; 2001 May; 280(5):E685-94. PubMed ID: 11287350
[TBL] [Abstract][Full Text] [Related]
64. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
65. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.
Sastre C; Fernández-Laso V; Madrigal-Matute J; Muñoz-García B; Moreno JA; Pastor-Vargas C; Llamas-Granda P; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
J Cell Mol Med; 2014 Apr; 18(4):721-34. PubMed ID: 24479820
[TBL] [Abstract][Full Text] [Related]
66. AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ.
Tiyerili V; Becher UM; Aksoy A; Lütjohann D; Wassmann S; Nickenig G; Mueller CF
Cardiovasc Diabetol; 2013 Feb; 12():30. PubMed ID: 23374104
[TBL] [Abstract][Full Text] [Related]
67. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
[TBL] [Abstract][Full Text] [Related]
68. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.
Brodeur MR; Bouvet C; Bouchard S; Moreau S; Leblond J; Deblois D; Moreau P
PLoS One; 2014; 9(1):e85922. PubMed ID: 24465790
[TBL] [Abstract][Full Text] [Related]
69. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
[TBL] [Abstract][Full Text] [Related]
70. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
[TBL] [Abstract][Full Text] [Related]
71. Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1.
Xu L; Wang YR; Li PC; Feng B
Circ J; 2019 Aug; 83(9):1954-1964. PubMed ID: 31378770
[TBL] [Abstract][Full Text] [Related]
72. Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways.
Kamioka M; Ishibashi T; Sugimoto K; Uekita H; Nagai R; Sakamoto N; Ando K; Ohkawara H; Teramoto T; Maruyama Y; Takeishi Y
J Atheroscler Thromb; 2010 Jun; 17(6):590-600. PubMed ID: 20379053
[TBL] [Abstract][Full Text] [Related]
73. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
Schmidt AM; Hori O; Chen JX; Li JF; Crandall J; Zhang J; Cao R; Yan SD; Brett J; Stern D
J Clin Invest; 1995 Sep; 96(3):1395-403. PubMed ID: 7544803
[TBL] [Abstract][Full Text] [Related]
74. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
[TBL] [Abstract][Full Text] [Related]
75. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
76. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
77. RAGE deficiency alleviates aortic valve calcification in ApoE
Wang B; Cai Z; Liu B; Liu Z; Zhou X; Dong N; Li F
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):781-792. PubMed ID: 28024939
[TBL] [Abstract][Full Text] [Related]
78. Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.
Koïtka A; Cao Z; Koh P; Watson AM; Sourris KC; Loufrani L; Soro-Paavonen A; Walther T; Woollard KJ; Jandeleit-Dahm KA; Cooper ME; Allen TJ
Diabetologia; 2010 Mar; 53(3):584-92. PubMed ID: 19957160
[TBL] [Abstract][Full Text] [Related]
79. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
Thomas M; Gavrila D; McCormick ML; Miller FJ; Daugherty A; Cassis LA; Dellsperger KC; Weintraub NL
Circulation; 2006 Aug; 114(5):404-413. PubMed ID: 16864727
[TBL] [Abstract][Full Text] [Related]
80. Unlocking the biology of RAGE in diabetic microvascular complications.
Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
